Mikala Egeblad
Impact in
- Cancer Research top 0.1%
- Protease and Inhibitor Mechanisms
- Immunology and Allergy top 0.1%
- Cell Adhesion Molecules Research
Papers in
- Oncology 37
- Cancer Cells and Metastasis 11
- Cancer Immunotherapy and Biomarkers 10
- Immunology 34
- Immune cells in cancer 19
- Immunotherapy and Immune Responses 12
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 10
- Co-authors
- Zena Werb (18 shared papers)Valerie M. Weaver (3 shared papers)Elizabeth S. Nakasone (5 shared papers)Morten G. Rasch (3 shared papers)Marja Jäättelä (5 shared papers)Johnathon N. Lakins (1 shared paper)Mitsuo Yamauchi (1 shared paper)Amato J. Giaccia (1 shared paper)
- Journals
- Cancer Cell (9 papers)Cancer Research (4 papers)Disease Models & Mechanisms (3 papers)Cold Spring Harbor Protocols (3 papers)Journal of Visualized Experiments (3 papers)
- Partner nations
- United StatesDenmarkUnited Kingdom
In The Last Decade
Mikala Egeblad
83 papers receiving 19.1k citations
Mikala Egeblad's Hit Papers
Peers
Comparison fields: 5 of 154
- Cancer Research 4.6k
- Immunology and Allergy 1.7k
- Oncology 6.6k
- Immunology 3.6k
- Cell Biology 2.7k
Countries citing papers authored by Mikala Egeblad
This map shows the geographic impact of Mikala Egeblad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikala Egeblad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikala Egeblad more than expected).
Fields of papers citing papers by Mikala Egeblad
This network shows the impact of papers produced by Mikala Egeblad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikala Egeblad. The network helps show where Mikala Egeblad may publish in the future.
Co-authors
The 25 scholars most cited alongside Mikala Egeblad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | New functions for the matrix metalloproteinases in cancer progression Hit paper breakdown → | 2002 | 4987 |
| 2 | Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling Hit paper breakdown → | 2009 | 3132 |
| 3 | The entry of nanoparticles into solid tumours Hit paper breakdown → | 2020 | 1343 |
| 4 | Neutrophil extracellular traps in COVID-19 Hit paper breakdown → | 2020 | 1106 |
| 5 | Tumors as Organs: Complex Tissues that Interface with the Entire Organism Hit paper breakdown → | 2010 | 924 |
| 6 | Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps Hit paper breakdown → | 2016 | 739 |
| 7 | Dynamic interplay between the collagen scaffold and tumor evolution Hit paper breakdown → | 2010 | 701 |
| 8 | Hsp70 exerts its anti‐apoptotic function downstream of caspase‐3‐like proteases Hit paper breakdown → | 1998 | 578 |
| 9 | Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Hit paper breakdown → | 2001 | 532 |
| 10 | Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss Hit paper breakdown → | 2015 | 473 |
| 11 | 2003 | 428 | |
| 12 | 2012 | 382 | |
| 13 | 2008 | 286 | |
| 14 | 2012 | 271 | |
| 15 | 2018 | 266 | |
| 16 | 2018 | 203 | |
| 17 | NETworking with cancer: The bidirectional interplay between cancer and neutrophil extracellular traps Hit paper breakdown → | 2023 | 193 |
| 18 | 2021 | 183 | |
| 19 | 1997 | 178 | |
| 20 | Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-β activation Hit paper breakdown → | 2023 | 166 |
About Mikala Egeblad
Mikala Egeblad is a scholar working on Oncology, Immunology, Molecular Biology, Cancer Research and Immunology and Allergy, having authored 84 papers that have together received 19.4k indexed citations. Recurring topics across this work include Immune cells in cancer (19 papers), Immunotherapy and Immune Responses (12 papers), Cell Adhesion Molecules Research (12 papers), Cancer Cells and Metastasis (11 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (10 papers), Cancer Immunotherapy and Biomarkers (10 papers), Nanoplatforms for cancer theranostics (9 papers) and Protease and Inhibitor Mechanisms (8 papers). The work is most often cited by research in Cancer Research (4.6k citations), Immunology and Allergy (1.7k citations), Oncology (6.6k citations), Immunology (3.6k citations) and Cell Biology (2.7k citations). Mikala Egeblad has collaborated with scholars based in United States, Denmark and United Kingdom. Frequent co-authors include Zena Werb, Valerie M. Weaver, Elizabeth S. Nakasone, Morten G. Rasch, Marja Jäättelä, Johnathon N. Lakins, Mitsuo Yamauchi, Amato J. Giaccia, Sheri F T Fong and Katalin Csiszár. Their work appears in journals such as Cancer Cell, Cancer Research, Disease Models & Mechanisms, Cold Spring Harbor Protocols and Journal of Visualized Experiments.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.